Italians approve Visipaque:
This article was originally published in Clinica
Executive Summary
Nycomed's X-ray contrast agent, Visipaque, has received marketing approval from the Italian Health Ministry. The approval, published in the Italian Gazzetta Ufficiale on April 22nd, lasts for five years.